Chlamydia Vaccine Shows Promise in Early Trial

A chlamydia vaccine has triggered an immune response in an early trial, raising hopes that it might help curb the spread of the sexually transmitted infection (STI).

Related Keywords

New York ,United States ,Denmark ,America ,David Harvey ,Hilary Reno ,Jay Varma ,Jes Dietrich ,Washington University School Of Medicine ,National Coalition ,Us Centers For Disease ,Louis County Sexual Health Clinic ,Healthday News ,Disease Control ,Lancet Infectious Diseases ,Weill Cornell Medicine ,New York City ,Washington University School ,Louis County Sexual Health ,Statens Serum Institut ,Vaccines ,Std ,News ,Chlamydia ,Infections ,